Tenet Healthcare (NYSE:THC) EVP Sells 24,000 Shares of Stock

Tenet Healthcare Corporation (NYSE:THC) EVP Lisa Foo sold 24,000 shares of the stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $266.32, for a total transaction of $6,391,680.00. Following the sale, the executive vice president owned 8,053 shares in the company, valued at approximately $2,144,674.96. The trade was a 74.88% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Tenet Healthcare Stock Down 0.2%

NYSE THC traded down $0.56 during mid-day trading on Tuesday, reaching $265.35. The stock had a trading volume of 815,961 shares, compared to its average volume of 758,688. The stock has a market cap of $21.37 billion, a PE ratio of 10.23, a price-to-earnings-growth ratio of 1.02 and a beta of 1.23. Tenet Healthcare Corporation has a 1 year low of $157.58 and a 1 year high of $283.05. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The company has a fifty day moving average price of $233.42 and a 200 day moving average price of $210.44.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. The business had revenue of $6.04 billion during the quarter, compared to analyst estimates of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the company earned $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, research analysts expect that Tenet Healthcare Corporation will post 20.98 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on THC. Weiss Ratings raised shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, August 20th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a research report on Monday, July 27th. Wall Street Zen raised Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a report on Sunday, August 23rd. UBS Group lifted their price objective on Tenet Healthcare from $288.00 to $308.00 and gave the stock a “buy” rating in a report on Monday, July 27th. Finally, The Goldman Sachs Group reissued a “buy” rating and issued a $305.00 target price on shares of Tenet Healthcare in a research report on Tuesday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $273.00.

Institutional Investors Weigh In On Tenet Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Tenet Healthcare during the 2nd quarter valued at $5,504,000. California State Teachers Retirement System grew its position in shares of Tenet Healthcare by 18,362.2% during the second quarter. California State Teachers Retirement System now owns 18,885,726 shares of the company’s stock worth $3,533,142,000 after purchasing an additional 18,783,432 shares in the last quarter. Compass Financial Management LLC purchased a new position in Tenet Healthcare in the 2nd quarter worth approximately $57,000. AlphaGrep UK Ltd purchased a new stake in Tenet Healthcare during the 2nd quarter valued at approximately $344,000. Finally, BAM Wealth Management LLC boosted its position in shares of Tenet Healthcare by 73.1% during the second quarter. BAM Wealth Management LLC now owns 2,421 shares of the company’s stock worth $453,000 after acquiring an additional 1,022 shares during the last quarter. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.